SABBY MANAGEMENT, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 64 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$79,000
-79.9%
10,815
-84.1%
0.02%
-80.0%
Q4 2020$393,000
+153.5%
68,092
+161.5%
0.08%
+226.1%
Q3 2020$155,000
-65.6%
26,039
-70.2%
0.02%
-74.4%
Q2 2020$450,000
+10.8%
87,319
-22.1%
0.09%
-46.7%
Q1 2020$406,000112,1550.17%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
PATHWAY CAPITAL MANAGEMENT, LP 245,606$3,671,8106.55%
AIGH Capital Management LLC 695,358$10,395,6023.42%
BARDIN HILL MANAGEMENT PARTNERS LP 638,360$9,5442.08%
Kellner Capital, LLC 100,016$1,4951.74%
NEXPOINT ASSET MANAGEMENT, L.P. 1,464,807$21,898,8651.70%
Worth Venture Partners, LLC 170,925$2,555,3291.51%
Birchview Capital, LP 100,000$1,4951.06%
BCK CAPITAL MANAGEMENT LP 68,000$1,016,6001.05%
WATER ISLAND CAPITAL LLC 698,915$10,4490.89%
EHP Funds Inc. 292,043$4,3660.82%
View complete list of AVEO PHARMACEUTICALS INC shareholders